- Report
- August 2024
- 100 Pages
Global
From €5231EUR$5,950USD£4,508GBP
- Report
- April 2025
- 175 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- July 2025
- 386 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- June 2025
- 400 Pages
Global
From €4351EUR$4,949USD£3,749GBP
- Report
- January 2024
- 150 Pages
Global
From €2857EUR$3,250USD£2,462GBP
€4264EUR$4,850USD£3,674GBP
- Report
- May 2024
- 137 Pages
Global
From €5714EUR$6,499USD£4,924GBP
- Report
- August 2022
- 110 Pages
Global
From €4176EUR$4,750USD£3,599GBP
- Report
- December 2023
- 300 Pages
Global
From €2198EUR$2,500USD£1,894GBP
- Report
- December 2023
- 80 Pages
Russia
From €1319EUR$1,500USD£1,136GBP
- Report
- December 2023
- 80 Pages
Poland
From €1319EUR$1,500USD£1,136GBP
- Report
- October 2023
- 300 Pages
Global
From €2198EUR$2,500USD£1,894GBP
- Report
- October 2023
- 100 Pages
Africa
From €1758EUR$2,000USD£1,515GBP
- Report
- October 2023
- 80 Pages
United States
From €1319EUR$1,500USD£1,136GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1319EUR$1,500USD£1,136GBP
From €1319EUR$1,500USD£1,136GBP
- Report
- October 2023
- 80 Pages
South Korea
From €1319EUR$1,500USD£1,136GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1319EUR$1,500USD£1,136GBP
- Report
- October 2023
- 80 Pages
India
From €1319EUR$1,500USD£1,136GBP
- Report
- October 2023
- 80 Pages
Germany
From €1319EUR$1,500USD£1,136GBP
- Report
- October 2023
- 80 Pages
France
From €1319EUR$1,500USD£1,136GBP

Propylthiouracil (PTU) is a medication used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. It is a thioamide drug, which works by blocking the production of thyroid hormones. PTU is used to treat Graves' disease, an autoimmune disorder that causes hyperthyroidism, as well as other forms of hyperthyroidism. PTU is also used to treat thyroid storm, a rare but serious condition in which the body produces too much thyroid hormone. PTU is part of the Endocrine and Metabolic Disorders Drugs market, which includes medications used to treat a variety of endocrine and metabolic disorders. These drugs are used to treat conditions such as diabetes, obesity, and thyroid disorders.
Companies in the Propylthiouracil market include Merck, Pfizer, Sanofi, and Mylan. Show Less Read more